The Effects of Curcumin on Patients with Colorectal Cancer
Phase 2
- Conditions
- Colorectal cancer.Malignant neoplasm of rectosigmoid junction
- Registration Number
- IRCT20080901001165N43
- Lead Sponsor
- Bagheiat-allah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Patients with colorectal cancer aged more than 20 years
Colorectal cancer patients (stage 3) who have undergone surgery and need chemotherapy
Exclusion Criteria
Age less than 20 years
Patients who need a change of the treatment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tumor necrosis factor alpha. Timepoint: Before the intervention and 8 weeks after taking drug or placebo. Method of measurement: Sandwich and competitive chemiluminescence immunoassays.;Interleukin 6. Timepoint: Before the intervention and 8 weeks after taking drug or placebo. Method of measurement: Sandwich and competitive chemiluminescence immunoassays.;Total quality of life score. Timepoint: Before the intervention and 8 weeks after taking drug or placebo. Method of measurement: Using EORTC QLQ questionnaire.
- Secondary Outcome Measures
Name Time Method